Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | SGN-ALPV |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
SGN-ALPV is a an antibody-drug conjugate (ADC) comprised of a monoclonal antibody targeting the placental alkaline phosphatases ALPP and ALPPL2, linked to monomethyl auristatin E (MMAE), with potential antitumor activity (Cancer Res 2022;82(12_Suppl):Abstract nr 1766). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| SGN-ALPV | SGN-ALPV | 0 | 1 |